Revlimid: Clinical Trials

6 trials of Revlimid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated, 1 unknown. 6 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 16Completed 2, Recruiting 2, Terminated 1, Unknown 1

Follow Revlimid: new trials by email Literature Review of Revlimid trials Research Report on Revlimid

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VitD3 Supplementation in Patients With Multiple Myeloma
Lenalidomide, Maintenance Vitamin D, No maintenance Vitamin D - Multiple Myeloma
Early Phase 1RecruitingAmany Keruakous, MD, MS.1002024-12-012025-04-08
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
Ruxolitinib Oral Tablet [Jakafi], Lenalidomide, Methylprednisolone - Multiple Myeloma
Early Phase 1RecruitingOncotherapeutics302022-12-082024-12-17
Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma
Biopsy Specimen Radiography, Lenalidomide, Vaccine Therapy - Smoldering Plasma Cell Myeloma
Early Phase 1CompletedM.D. Anderson Cancer Center302018-12-212025-12-19
Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome
Dexamethasone, Ixazomib Citrate, Lenalidomide - Plasmacytoma, POEMS Syndrome
Early Phase 1CompletedMayo Clinic212016-10-312025-02-12
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Filgrastim, Bortezomib, Carfilzomib - Multiple Myeloma
Early Phase 1TerminatedWashington University School of Medicine72012-06-012015-01-26
Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
Lenalidomide + Ancestim - Myelodysplasia
Early Phase 1UnknownPeter MacCallum Cancer Centre, Australia252007-02-012013-01-10

Conditions studied

Multiple Myeloma (3)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  POEMS Syndrome (1)  ·  Plasmacytoma (1)  ·  Smoldering Multiple Myeloma (1)  ·  Vitamin D Deficiency (1)

Sponsors

Amany Keruakous, MD, MS. (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Oncotherapeutics (1)  ·  Peter MacCallum Cancer Centre, Australia (1)  ·  Washington University School of Medicine (1)

Countries

United States (5)  ·  Australia (1)

Top investigators

Amany Keruakous, MD (1)  ·  Angela Dispenzieri, M.D. (1)  ·  James Berenson, MD (1)  ·  Krina Patel (1)  ·  Miles Prince, Prof. (1)  ·  Ravi Vij, M.D. (1)